Purpose: Multidrug resistant (MDR) Klebsiella pneumoniae (Kp) is a worldwide concern worsened by colistin resistance emergence. In this study, molecular epidemiology of clinical MDR Kp strains is described, assessing clonal relationships and resistance genes profiles. Prevalence of Extended-Spectrum Beta-Lactamase (ESBL) blaCTX-M, blaTEM and blaSHV genes was evaluated, as well as that associated to carbapenems (blaKPC, blaGES, blaVIM, blaIMP, blaNDM, blaOXA-48) and colistin resistance (mcr-1,2,3,4 and mgrB). Methods & Materials: Twenty-six Kp cultures were collected from âŁœA.Cardarelli⣞ hospital in Molise Region (Central Italy), 57.7% from Intensive Care Unit (ICU). The Minimum Inhibitory Concentration (MIC) was assessed by BD Phoenixâ„¢. Genotyping was achieved through Pulsed-Field Gel Electrophoresis (PFGE) withXbaI and MultiLocus Sequence Typing (MLST). PCRs for resistance genes detection and mgrB sequencing were performed. Results: Most (n = 20, 77%) strains were carbapenems resistant (imipenem, meropenem, ertapenem), and 53% (n = 14) to colistin. A higher prevalence of blaKPC (100%) and blaSHV (96.2%) was found compared with blaTEM (88.5%), blaVIM (69.0%) and blaCTX-M (7.7%). While none colistin-resistant (col-R) strain carried mcr-1,2,3,4 variants, 42.8% (n = 6) had an Insertion Sequence (IS) in mgrB, identified as IS5-like (5/14, 36%) and ISKpn14 (1/14, 7%). The prevalent Sequence Type was ST512 (50%), followed by ST101 (38.5%) and ST307 (11.5%). PFGE detected 12 clusters and 18 pulsotypes (95% similarity), and was more discriminating than MLST (Simpson’s Index 95%vs 61%). An ICU outbreak, during November 2014-January 2015, included five ST512 strains, blaTEM/blaSHV/blaVIM/blaKPC positive, and col-R due to mgrB IS5-like. Conclusion: Molecular epidemiology study identified an outbreak caused by poor compliance with hygienic standards because of reduced personnel during Christmas holidays. Although ST258 is the most prevalent in Italy, half strains were typed as ST512 that represents its monoallelic variant. Our results confirm the endemic blaKPC distribution and blaTEM/blaSHV as the prevalent ESBLs in Kp hospital outbreaks. According to epidemiological data, plasmid mcr variants were not found in col-R strains. Conversely, IS elements prevalence in mgrB explain resistance in about half col-R strains, and was in line with Italian data. Further investigations are needed to identify mgrB mutations in IS negative col-R strains.

Colistin resistance beyond carbapenems: molecular epidemiology of multi-drug resistant Klebsiella pneumoniae from an Italian hospital / Di Tella, D.; Tamburro, M.; Fanelli, I.; Guerrizio, G.; Sammarco, M. L.; Salzo, A.; Ripabelli, G.. - In: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. - ISSN 1201-9712. - 79:(2019), pp. 83-83. (Intervento presentato al convegno International meeting on emerging diseases and surveillance - IMED 2018 tenutosi a Vienna) [10.1016/j.ijid.2018.11.210].

Colistin resistance beyond carbapenems: molecular epidemiology of multi-drug resistant Klebsiella pneumoniae from an Italian hospital

Guerrizio, G.;
2019

Abstract

Purpose: Multidrug resistant (MDR) Klebsiella pneumoniae (Kp) is a worldwide concern worsened by colistin resistance emergence. In this study, molecular epidemiology of clinical MDR Kp strains is described, assessing clonal relationships and resistance genes profiles. Prevalence of Extended-Spectrum Beta-Lactamase (ESBL) blaCTX-M, blaTEM and blaSHV genes was evaluated, as well as that associated to carbapenems (blaKPC, blaGES, blaVIM, blaIMP, blaNDM, blaOXA-48) and colistin resistance (mcr-1,2,3,4 and mgrB). Methods & Materials: Twenty-six Kp cultures were collected from âŁœA.Cardarelli⣞ hospital in Molise Region (Central Italy), 57.7% from Intensive Care Unit (ICU). The Minimum Inhibitory Concentration (MIC) was assessed by BD Phoenixâ„¢. Genotyping was achieved through Pulsed-Field Gel Electrophoresis (PFGE) withXbaI and MultiLocus Sequence Typing (MLST). PCRs for resistance genes detection and mgrB sequencing were performed. Results: Most (n = 20, 77%) strains were carbapenems resistant (imipenem, meropenem, ertapenem), and 53% (n = 14) to colistin. A higher prevalence of blaKPC (100%) and blaSHV (96.2%) was found compared with blaTEM (88.5%), blaVIM (69.0%) and blaCTX-M (7.7%). While none colistin-resistant (col-R) strain carried mcr-1,2,3,4 variants, 42.8% (n = 6) had an Insertion Sequence (IS) in mgrB, identified as IS5-like (5/14, 36%) and ISKpn14 (1/14, 7%). The prevalent Sequence Type was ST512 (50%), followed by ST101 (38.5%) and ST307 (11.5%). PFGE detected 12 clusters and 18 pulsotypes (95% similarity), and was more discriminating than MLST (Simpson’s Index 95%vs 61%). An ICU outbreak, during November 2014-January 2015, included five ST512 strains, blaTEM/blaSHV/blaVIM/blaKPC positive, and col-R due to mgrB IS5-like. Conclusion: Molecular epidemiology study identified an outbreak caused by poor compliance with hygienic standards because of reduced personnel during Christmas holidays. Although ST258 is the most prevalent in Italy, half strains were typed as ST512 that represents its monoallelic variant. Our results confirm the endemic blaKPC distribution and blaTEM/blaSHV as the prevalent ESBLs in Kp hospital outbreaks. According to epidemiological data, plasmid mcr variants were not found in col-R strains. Conversely, IS elements prevalence in mgrB explain resistance in about half col-R strains, and was in line with Italian data. Further investigations are needed to identify mgrB mutations in IS negative col-R strains.
2019
International meeting on emerging diseases and surveillance - IMED 2018
ANTIMICROBIAL RESISTANCE; KLEBSIELLA PNEUMONIAE; COLISTIN; MDR
04 Pubblicazione in atti di convegno::04c Atto di convegno in rivista
Colistin resistance beyond carbapenems: molecular epidemiology of multi-drug resistant Klebsiella pneumoniae from an Italian hospital / Di Tella, D.; Tamburro, M.; Fanelli, I.; Guerrizio, G.; Sammarco, M. L.; Salzo, A.; Ripabelli, G.. - In: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. - ISSN 1201-9712. - 79:(2019), pp. 83-83. (Intervento presentato al convegno International meeting on emerging diseases and surveillance - IMED 2018 tenutosi a Vienna) [10.1016/j.ijid.2018.11.210].
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1561037
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact